NCT05372367 2026-02-03
A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor
Boehringer Ingelheim
Phase 1 Completed
Boehringer Ingelheim
Ipsen
Nuvation Bio Inc.
BeiGene
Jiangsu HengRui Medicine Co., Ltd.
AstraZeneca
Impact Therapeutics, Inc.
Odonate Therapeutics, Inc.
Pfizer
AstraZeneca
AstraZeneca
Abbott